site stats

Recursion therapeutics stock

WebApr 11, 2024 · The 15 analysts offering price forecasts for Recursion Pharmaceuticals, have a median target of 19.93, with a high estimate of 37.00 and a low estimate of 7.00. The median estimate represents a... WebMar 17, 2024 · Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of -8.57% and 37.04%, respectively, for the quarter ended June 2024. Do the numbers hold …

Recursion (@RecursionPharma) Twitter

WebRecursion Pharmaceuticals started at buy with $31 stock price target at BofA Securities May. 11, 2024 at 9:44 a.m. ET by Tomi Kilgore Recursion Pharmaceuticals started at … WebJul 13, 2024 · SALT LAKE CITY, July 13, 2024 - Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its formation of a Therapeutics Advisory Board (TAB), chaired by Joseph Miletich, MD, PhD. … gst 104 use of library material https://roschi.net

RXRX Recursion Pharmaceuticals Inc. Stock Price & News - WSJ

WebMar 28, 2024 · Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the Recursion OS, a platform built … WebApr 5, 2024 · The latest price target for Recursion Pharmaceuticals ( NASDAQ: RXRX) was reported by Needham on Thursday, March 16, 2024. The analyst firm set a price target for 17.00 expecting RXRX to rise to ... WebApr 10, 2024 · SVB Securities analyst Mani Foroohar reiterated a Hold rating on Recursion Pharmaceuticals (RXRX - Research Report) on February 27 and set a price target of $9.00. … financial annual turnover meaning

RXRX Stock News RECURSION PHARMACEUTICALS, Stock …

Category:RECURSION PHARMACEUTICALS, INC. - MarketScreener.com

Tags:Recursion therapeutics stock

Recursion therapeutics stock

Recursion Pharmaceuticals Inc - Ordinary Shares - Class …

WebRecursion Pharmaceuticals Overview Update this profile Founded 2013 Status Public Employees 500 Stock Symbol RXRX Investments 2 Share Price $6.65 (As of Thursday … WebRecursion Pharmaceuticals - Crunchbase Company Profile & Funding Oops! There was a problem! There was an unexpected issue while trying to process your request. Please …

Recursion therapeutics stock

Did you know?

WebNews Recursion Pharmaceuticals Inc. Significant News Only No significant news for RXRX in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-1.44 Market Cap … WebRecursion Pharmaceuticals is registered under the ticker NASDAQ:RXRX . Their stock opened with $18.00 in its Apr 16, 2024 IPO. Stock Symbol NASDAQ:RXRX Valuation at IPO …

WebFeb 17, 2024 · Recursion Pharmaceuticals completed its IPO in 2024, raising >$500m. The company is promising to revolutionize drug discovery with AI - although the evidence for that has not been especially... WebApr 11, 2024 · According to analysts, Recursion Pharmaceuticals's stock has a predicted upside of 36.20% based on their 12-month price targets. What analysts cover Recursion …

WebWe operate at the intersection and cutting-edge of science and technology. Unlike traditional biotechnology companies, our rapidly growing team of more than 200 Recursionauts is … WebRXRX Recursion Pharmaceuticals Inc - Ordinary Shares - Class A 559 Watch $6.65 $0.20 (3.10%) Today $6.52 0.13 (1.96%) After Hours Market Cap $1.27B Volume (M) 907,850.00 …

WebRecursion Pharmaceuticals Inc Follow Share $7.43 After Hours: $7.43 (0.00%) 0.00 Closed: Mar 21, 4:01:10 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Pfizer Inc. $40.66 PFE0.37% NVIDIA...

WebDiscover historical prices for RXRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Recursion Pharmaceuticals, Inc. stock was issued. gst 103 nigerian people and culture summaryWebApr 7, 2024 · Recursion Pharmaceuticals Inc stock has a Growth Score of 27, Momentum Score of 63 and Quality Score of 17. Comparing Denali Therapeutics Inc and Recursion … gst 107 summaryWebFind the latest Tango Therapeutics, Inc. (TNGX) stock quote, history, news and other vital information to help you with your stock trading and investing. gst111 craWebGet the latest Recursion Pharmaceuticals Inc (RXRX) real-time quote, historical performance, charts, and other financial information to help you make more informed … gst 111 communication in englishWebMar 16, 2024 · In a report released today, Gil Blum from Needham initiated coverage with a Buy rating on Recursion Pharmaceuticals and a price target of $17.00. The company’s … gst120a24-cinWebApr 12, 2024 · 5 analysts have issued 12-month price objectives for Recursion Pharmaceuticals' stock. Their RXRX share price forecasts range from $8.00 to $20.00. On … gst 10th icse mcqWebDec 7, 2024 · Recursion will work with both Roche and Genentech's R&D units to leverage technology-enabled drug discovery through the Recursion Operating System (OS) to more rapidly identify novel targets and ... financial apocalypse bert dohmen